4 found
Order:
  1.  10
    Shifting from Equality toward Equity: Addressing Disparities in Research Participation for Clinical Cancer Research.Andrew Hantel, Gregory A. Abel, Jeffrey M. Peppercorn, Jonathan M. Marron & Elizabeth Warner - 2024 - Journal of Clinical Ethics 35 (1):8-22.
    There is societal consensus that cancer clinical trial participation is unjust because some sociodemographic groups have been systematically underrepresented. Despite this, neither a definition nor an ethical explication for the justice norm of equity has been clearly articulated in this setting, leading to confusion over its application and goals. Herein we define equity as acknowledging sociodemographic circumstances and apportioning resource and opportunity allocation to eliminate disparities in outcomes, and we explore the issues and tensions this norm generates through practical examples. (...)
    Direct download  
     
    Export citation  
     
    Bookmark  
  2.  8
    Establishing and Defining an Approach to Climate Conscious Clinical Medical Ethics.Andrew Hantel, Jonathan M. Marron & Gregory A. Abel - forthcoming - American Journal of Bioethics:1-14.
    An anthropocentric scope for clinical medical ethics (CME) has largely separated this area of bioethics from environmental concerns. In this article, we first identify and reconcile the ethical issues imposed on CME by climate change including the dispersion of related causes and effects, the transdisciplinary and transhuman nature of climate change, and the historic divorce of CME from the environment. We then establish how several moral theories undergirding modern CME, such as virtue ethics, feminist ethics, and several theories of justice, (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  3.  9
    A Protocol and Ethical Framework for the Distribution of Rationed Chemotherapy.Andrew Hantel - 2014 - Journal of Clinical Ethics 25 (2):102-115.
    Shortages of generic, injectable chemotherapeutics have been increasing in prevalence since 2006. Due to the lack of access to first-line, lifesaving treatments, physicians have been forced to ration chemotherapy between patients. Although the scarcity has been managed with good intentions, it has been done in an ad hoc manner, without the benefit of an ethically grounded and standardized schema. Using an approach based on the “accountability for reasonableness” method by Daniel and Sabin, I establish a framework and protocol for rationing (...)
    Direct download  
     
    Export citation  
     
    Bookmark  
  4.  26
    Practical allocation system for the distribution of specialised care during cellular therapy access scarcity.Andrew Hantel, Gregory A. Abel & Mark Siegler - 2019 - Journal of Medical Ethics 45 (8):532-537.
    Novel cellular therapy techniques promise to cure many haematology patients refractory to other treatment modalities. These therapies are intensive and require referral to and care from specialised providers. In the USA, this pool of providers is not expanding at a rate necessary to meet expected demand; therefore, access scarcity appears forthcoming and is likely to be widespread. To maintain fair access to these scarce and curative therapies, we must prospectively create a just and practical system to distribute care. In this (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark